Search clinical trials for: Insuline glargine
Total 2818 results
-
Amsterdam UMC, location VUmcCompletedObesity | Type 2 DiabetesNetherlands
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentUnknownInsulin-requiring Type 2 Diabetes MellitusGermany
-
Loyola UniversitySanofiCompletedRenal Insufficiency | Type 2 DiabetesUnited States
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
SanofiCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
University of the Highlands and IslandsCompletedEndothelial DysfunctionUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines
-
The Coca-Cola CompanyCompletedObesity | OverweightSpain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
HealthPartners InstituteTerminated
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
SanofiCompleted
-
Emory UniversityCompletedHyperglycemiaUnited States
-
Sansum Diabetes Research InstituteNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 DiabetesUnited States
-
Hospital Central "Dr. Ignacio Morones Prieto"CompletedAngiogenesis | Varicose Ulcer | Insulin | Wound Healing | Chronic Venous DiseaseMexico
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Eli Lilly and CompanyCompleted
-
Fundación Pública Andaluza para la Investigación...CompletedType 1 Diabetes MellitusSpain
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
Laniado HospitalTerminatedDiabetes Mellitus Type 2Israel
-
Chungbuk National University HospitalActive, not recruitingType 2 Diabetes Mellitus | Glucose, High BloodKorea, Republic of
-
SanofiCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
University of GuadalajaraCompletedType 2 Diabetes MellitusMexico
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Northwestern UniversityTerminatedInsulin Resistance, Diabetes | Hyperglycemia Steroid-inducedUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina
-
Emory UniversityAmerican Diabetes AssociationCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland
-
Population Health Research InstituteAstraZenecaCompletedType 2 Diabetes MellitusCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan